Skip to main content
Free access
Industry Update
27 October 2021

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 4

Abstract

In this month’s round up, we discuss a number of recent publications and guidelines addressing the use of real-world evidence to evaluate the clinical benefit of health technology assessments and what the publications mean practically for manufacturers.

Formats available

You can view the full content in the following formats:

References

1.
Jaksa A, Wu J, Jónsson P, Eichler H-G, Vititoe S, Gatto NM. Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance. J. Comp. Eff. Res. 10(9), 711–731 (2021).
2.
Kent S, Salcher-Konrad M, Boccia S et al. The use of nonrandomized evidence to estimate treatment effects in health technology assessment. J. Comp. Eff. Res. 10(4), 1035–1043 (2021).
3.
Fernandez J, Taransaud J, Grande M et al. Real-world studies for the assessment of medicinal products and medical devices. https://www.has-sante.fr/upload/docs/application/pdf/2021-06/real-world_studies_for_the_assessment_of_medicinal_products_and_medical_devices.pdf